Cardiovascular disease: risk assessment and reduction, including lipid modification

National Institute for Health and Care Excellence

Cardiovascular disease (CVD) is the leading cause of death in England and Wales. Blood cholesterol is a key modifiable risk factor for CVD.

It is estimated that in Britain, approximately 66% of men and women have blood cholesterol levels in excess of 5.0 mmol/l

This Guidelines summary covers the primary and secondary prevention of CVD, which is outlined in a lipid modification therapy algorithm.

Log in or register now for FREE in order to:

  • benefit from unlimited access to all pages, including:
    • 180+ guideline summaries
    • 1000+ evidence-based articles
  • review and leave comments on all articles and summaries
  • automatically track your reading and learning via your CPD tracker
  • on-demand webinars presented by leading clinical experts

Registration only takes 2 minutes and it will give you FREE access to all content across:



Need help? Email us